GCL Energy Technology (002015.SZ) subsidiary plans to invest 100 million yuan to participate in the Lishi Xing Shen Fund.

20:41 08/09/2026

Xiexin Energy Technology Co., Ltd. (002015.SZ) announced that its wholly-owned subsidiary, Xinneng Wei Lai (Suzhou) Industrial Investment Co., Ltd., as one of the limited partners (LP), has recently signed a partnership agreement with the general partner (GP) Tianjin Li Si Ming Tang Enterprise Management Consulting Partnership (Limited Partnership) and other limited partners. The company plans to invest 100 million yuan of its own funds to participate in the subscription of partnership shares in Tianjin Li Si Xing Shen Equity Investment Partnership (Limited Partnership) (referred to as "Li Si Xing Shen"). The initial fundraising scale of this fund is 1.74 billion yuan, which will mainly target emerging technology-related fields.

GCL Energy Technology (002015.SZ) announced that recently, its wholly-owned subsidiary, Xin Weilai (Suzhou) Industrial Investment Co., Ltd., as one of the limited partners (LP), signed a partnership agreement with general partner (GP) Tianjin Lisi Mingtang Enterprise Management Consulting Partnership (Limited Partnership) and other limited partners. The company intends to use its own funds to contribute 100 million yuan to participate in the subscription of partnership interests in Tianjin Lisi Xing Shen Equity Investment Partnership (Limited Partnership) (referred to as "Lisi Xing Shen"). The initial fundraising scale of this fund is 1.74 billion yuan and will primarily focus on emerging technology-related fields.

YUEXIUTRANSPORT (01052): Liu Yan appointed as Chairman.

Henan Yuneng Holdings (001896.SZ) plans to increase the capital of its subsidiary Lushan Pumped Storage by 340 million yuan.

HBM HOLDINGS-B (02142): Positive interim results from the Phase II clinical trial of HBM9378/WIN378 for the treatment of asthma and the initiation of Phase III study.

YUEXIUTRANSPORT (01052): Liu Yan appointed as Chairman.

Henan Yuneng Holdings (001896.SZ) plans to increase the capital of its subsidiary Lushan Pumped Storage by 340 million yuan.

HBM HOLDINGS-B (02142): Positive interim results from the Phase II clinical trial of HBM9378/WIN378 for the treatment of asthma and the initiation of Phase III study.